LA SCLEROSI MULTIPLA: UPDATE 2025

1. 1.Iaffaldano P, Lucisano G, Caputo F, et al.. Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies. Ther Adv Neurol Disord. 2021 May 31:14:17562864211019574. doi: 10.1177/17562864211019574. eCollection 2021.. 2021
   Articolo scientificoTher Adv Neurol Disord. 2021 May 31:14:17562864211019574. doi: 10.1177/17562864211019574. eCollection 2021.Leggi il PDF gratuito
2. 2.Canto-Gomes J, Boleixa D, Teixeira C, Martins da Silva A, González-Suárez I, Cerqueira J, Correia-Neves M, Nobrega C.. Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis.. Int Immunopharmacol. 2024 Apr 20;131:111826. doi: 10.1016/j.intimp.2024.111826. Epub 2024 Mar 10. Erratum in: Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113555. doi: 10.1016/j.intimp.2024.113555. PMID: 38461632.. 2024
   Articolo scientificoInt Immunopharmacol. 2024 Apr 20;131:111826. doi: 10.1016/j.intimp.2024.111826. Epub 2024 Mar 10. Erratum in: Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113555. doi: 10.1016/j.intimp.2024.113555. PMID: 38461632.Leggi il PDF gratuito
3. 3.Rui Li , Kristina R Patterson , Amit Bar-Or. Reassessing B cell contributions in multiple sclerosis. Nat Immunol 2018 Jul;19(7):696-707.. 2018
   Articolo scientificoNat Immunol 2018 Jul;19(7):696-707.Leggi il paperCerca versione gratuita
4. 4.Filippi, Massimo et al.. Early use of high-efficacy disease modifying therapies makes the difference in people with multiple sclerosis: an expert opinion. Journal of neurology vol. 269,10. 2022
   Articolo scientificoJournal of neurology vol. 269,10Leggi il PDF gratuito
5. 5.Giovannoni Gavin, et al.. A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis. Neurology and therapy vol. 9,2. 2020
   Articolo scientificoNeurology and therapy vol. 9,2Leggi il PDF gratuito

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).